IMPEL NEUROPHARMA INC — Form D

IMPEL NEUROPHARMA INC of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2021-04-01. The offering totals $1.9M. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Adrian D AdamsDirectorSeattle, WA
David D AllisonDirector
John D HoekmanDirectorSeattle, WA
Robert D MittendorffDirectorBelmont, CA
Tim D NelsonDirectorSeattle, WA
Stewart D ParkerDirectorSeattle, WA
Aaron D RoystonDirectorSeattle, WA
Ali D SatvatDirectorSeattle, WA
Mahendra D ShahDirectorSeattle, WA
Diane D WilfongDirectorSeattle, WA
Adrian D AdamsExecutive OfficerSeattle, WA
John D HoekmanExecutive OfficerSeattle, WA
John D LeamanExecutive OfficerSeattle, WA
Jon D CongletonDirectorSeattle, WA
Jon D CongletonExecutive OfficerSeattle, WA
Jim D YoungDirectorSeattle, WA
Michael D HiteDirectorSeattle, WA
Michael P HiteDirectorSeattle, WA
Michael P HiteExecutive OfficerSeattle, WA
Rodney D HoDirectorSeattle, WA
Michael P. HiteDirectorSeattle, WA
Michael P. HiteExecutive OfficerSeattle, WA
Rodney D. HoDirectorSeattle, WA
John D. HoekmanDirectorSeattle, WA
John D. HoekmanExecutive OfficerSeattle, WA

Other filings by this issuer (15)

FiledFormOfferingSold
2021-03-12D$7.5M$7.5M
2021-02-17D$490K
2020-05-06D$5.6M
2020-01-30D$481K
2019-07-03D$1.6M
2019-02-22D$1.4M
2016-12-01D$37.3M$22.3M
2016-10-18D$80K$80K
2016-08-29D$2.0M$1.1M
2015-09-18D$12.0M$4.0M
2015-09-14D$1.3M$1.3M
2013-11-27D$3.8M$2.6M
2012-08-10D$500K$25K
2011-09-20D$2.0M$527K
2010-01-21D$1.5M$305K

More